NCL1 is a phenylcyclopropylamine (PCPA)-based Lysine-specific demethylase 1 (LSD1) inhibitor. NCL1 selectively inhibits LSD1 in preference to LSD2, with IC50 values of 2.5 and 26 µM for LSD1 and LSD2, respectively[1].
Molecular Weight:
443.54
CAS Number:
[1196119-03-5]
Formula:
C27H29N3O3
Target:
Histone Demethylase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
